Literature DB >> 2050942

The Marfan syndrome: abnormal aortic elastic properties.

K Hirata1, F Triposkiadis, E Sparks, J Bowen, C F Wooley, H Boudoulas.   

Abstract

Aortic distensibility and aortic stiffness index were measured at the ascending aorta (3 cm above the aortic valve) and the mid-portion of the abdominal aorta from the changes in echocardiographic diameters and pulse pressure in 14 patients with the Marfan syndrome and 15 age- and gender-matched normal control subjects. The following formulas were used: 1) Aortic distensibility = 2(Changes in aortic diameter)/(Diastolic aortic diameter) (Pulse pressure); and 2) Aortic stiffness index = ln(Systolic blood pressure)/(Diastolic blood pressure)(Changes in aortic diameter)/Diastolic aortic diameter. Pulse wave velocity was also measured. Compared with normal subjects, patients with the Marfan syndrome had decreased aortic distensibility in the ascending and the abdominal aorta (2.9 +/- 1.3 vs. 5.6 +/- 1.4 cm2 dynes-1, p less than 0.001 and 4.5 +/- 2.1, vs. 7.7 +/- 2.5, cm2 dynes-1, p less than 0.001, respectively) and had an increased aortic stiffness index in the ascending and the abdominal aorta (10.9 +/- 5.6 vs. 5.9 +/- 2.2, p less than 0.005 and 7.1 +/- 3.1 vs. 3.9 +/- 1.2, p less than 0.005, respectively). Aortic diameters in the ascending aorta were larger in these patients than in normal subjects, but those in the abdominal aorta were similar in the two groups. Linear correlations for both aortic distensibility and stiffness index were found between the ascending and the abdominal aorta (r = 0.85 and 0.71, respectively). Pulse wave velocity was more rapid in the patients than in the normal subjects (11.6 +/- 2.5 vs. 9.5 +/- 1.4 m/s, respectively, p less than 0.01). Thus, aortic elastic properties are abnormal in patients with the Marfan syndrome irrespective of the aortic diameter, which suggests an intrinsic abnormality of the aortic arterial wall.

Entities:  

Mesh:

Year:  1991        PMID: 2050942     DOI: 10.1016/s0735-1097(10)80218-9

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  39 in total

1.  Survival and complication free survival in Marfan's syndrome: implications of current guidelines.

Authors:  M Groenink; T A Lohuis; J G Tijssen; M S Naeff; R C Hennekam; E E van der Wall; B J Mulder
Journal:  Heart       Date:  1999-10       Impact factor: 5.994

2.  Wall motion velocities of abdominal aorta measured by tissue Doppler imaging in normal children.

Authors:  K Yasuoka; K Harada
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

3.  Age-dependent changes in elastic properties of thoracic aorta evaluated by magnetic resonance in normal subjects.

Authors:  Giovanni Donato Aquaro; Alessandro Cagnolo; Kaushal Kumar Tiwari; Giancarlo Todiere; Stefano Bevilacqua; Gianluca Di Bella; Lamia Ait-Ali; Pierluigi Festa; Mattia Glauber; Massimo Lombardi
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-06-12

4.  Pulse wave imaging for noninvasive and quantitative measurement of arterial stiffness in vivo.

Authors:  Jonathan Vappou; Jianwen Luo; Elisa E Konofagou
Journal:  Am J Hypertens       Date:  2010-01-21       Impact factor: 2.689

5.  Accuracy of arterial pulse-wave velocity measurement using MR.

Authors:  B D Bolster; E Atalar; C J Hardy; E R McVeigh
Journal:  J Magn Reson Imaging       Date:  1998 Jul-Aug       Impact factor: 4.813

6.  Detection of abnormal aortic elastic properties in asymptomatic patients with Marfan syndrome by combined transoesophageal echocardiography and acoustic quantification.

Authors:  A Franke; E G Mühler; H G Klues; K Peters; W Lepper; G von Bernuth; P Hanrath
Journal:  Heart       Date:  1996-03       Impact factor: 5.994

Review 7.  Surgical implication of aortic dissection on long-term outcome in Marfan patients.

Authors:  J Hayashi; H Moro; O Namura; N Yagi; H Ohzeki; H Watanabe; H Miyamura; S Eguchi; M Kimura
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

8.  Influence of antihypertensive therapy with cilazapril and hydrochlorothiazide on the stiffness of the aorta.

Authors:  K Breithaupt-Grögler; M Leschinger; G G Belz; R Butzer; K Erb; C de May; W Sinn
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

9.  [Marfan syndrome and valvular disease].

Authors:  M Pasic; M Bauer; R Hetzer
Journal:  Z Kardiol       Date:  2001-12

10.  Arterial stiffness in the young: assessment, determinants, and implications.

Authors:  Yiu-Fai Cheung
Journal:  Korean Circ J       Date:  2010-04-22       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.